Industry Summits
Walgreen makes Times Square return as it revamps
CHICAGO (Reuters) - Walgreen Co has more than 6,500 drugstores across the United States, but only one of them can help the chain reach billions of people, even if they never step inside. Full Article
Daiichi confident of Effient approval
NEW YORK (Reuters) - Daiichi-Sankyo's top U.S. executive expressed confidence that the blood clot preventer it is developing with Eli Lilly & Co will soon win U.S. approval, and said the sales force for the medicine was champing at the bit to get started. Full Article
Summit Video
Gilead: focus on hepatitis treatment
Nov 19 - Gilead Sciences expects the market for drugs to treat hepatitis B and C to grow significantly in the coming years. Play Video
Sign up here to be alerted via email about top news broken from these exclusive interviews, as well as the list of guests for upcoming Reuters Summits.
Big Pharma seeks to shape U.S. health plan
NEW YORK (Reuters) - Major drug makers want their voices heard as U.S. Democrats, traditionally critics of the industry, start crafting plans to expand health insurance coverage and cut the escalating costs of care. Full Article
Aetna CEO says taking market share
NEW YORK (Reuters) - Aetna Inc is confident in its prospects and is taking market share despite uncertainty over health-care reform and the broader economic climate that has weighed on its shares, the head of the No. 3 U.S. health insurer said on Wednesday. Full Article
Merck eyes deals, growth through 2013
NEW YORK (Reuters) - Merck & Co Inc's CEO sees profit growth from 2010 to 2013 despite looming generic competition for two of its biggest drugs, and has the appetite to buy a big biotechnology company if the right deal comes along. Full Article
Healthy Bayer plays down bid talk
NEW YORK (Reuters) - Bayer AG's buoyant health care business will help the drugs-chemicals hybrid ride out recession, and the same conglomerate structure makes it an unlikely bid target, a top executive said on Wednesday. Full Article
Aetna CEO sees no end to employer-based insurance
NEW YORK (Reuters) - Employer-provided health care benefits are not likely to disappear even as a growing number of Americans lose their jobs amid a struggling economy, the head of the nation's third-largest health insurer said on Wednesday. Full Article
Novartis could cut drug development by a year
NEW YORK (Reuters) - A new way of conducting clinical trials could allow Novartis AG to cut the time needed to develop some drugs by a year, the Swiss drug maker's designated development head said on Wednesday. Full Article
Walgreen eyes growth despite slowdown
CHICAGO (Reuters) - Walgreen Co expects to increase its share of prescription sales even as anxious consumers rein in spending in the tough economic climate, said President and Chief Operating Officer Greg Wasson. Full Article
More Health News
Speakers
| India Investment | Nov 24 - 26 | Mumbai and Bangalore |
| Media | Dec 1 - 4 | New York |
| Investment Outlook | Dec 8 - 11 | New York |
| Aerospace and Defense | Dec 15 - 17 | Washington, DC |
